Full Papers
Implications of thyroid-related autoantibodies in patients with Sjögren’s syndrome without overt thyroid diseases
Y.-J. Ha1, J.-I. Lee2, S.R. Choi3, E.H. Kang4, K.-S. Kim5, W.-J. Jeong6, J.Y. Hyon7, M.J. Kim8, S. Cha9, Y.J. Lee10
- Division of Rheumatology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, and Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
- Division of Rheumatology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
- Division of Rheumatology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, and Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
- Division of Rheumatology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, and Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
- Department of Periodontology, Section of Dentistry, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
- Department of Otorhinolaryngology, Head & Neck Surgery, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
- Department of Ophthalmology, Seoul National University Bundang Hospital, Seongnam, Republic of Korea.
- Division or Endocrinology, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Republic of Korea.
- Division of Oral Medicine, Department of Oral and Maxillofacial Diagnostic Sciences, University of Florida College of Dentistry, Gainesville, FL, USA.
- Division of Rheumatology, Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam; Department of Internal Medicine, Seoul National University College of Medicine, Seoul; and Department of Medical Device Development, Seoul National University College of Medicine, Seoul, Republic of Korea. yn35@snu.ac.kr
CER17688
2024 Vol.42, N°12
PI 2404, PF 2411
Full Papers
Free to view
(click on article PDF icon to read the article)
PMID: 39625822 [PubMed]
Received: 17/03/2024
Accepted : 06/05/2024
In Press: 15/11/2024
Published: 19/12/2024
Abstract
OBJECTIVES:
We investigated the prevalence of anti-thyroid autoantibodies and thyroid dysfunction, and their association with clinical and laboratory features in Korean patients with primary Sjögren’s syndrome (pSS) without overt thyroid illnesses.
METHODS:
We consequently included 196 pSS patients (190 women) and cross-sectionally collected clinical and laboratory data including the EULAR Sjögren’s Syndrome Disease Activity Index (ESSDAI) and Patient Reported Index (ESSPRI). The fatigue-dominant group was defined as those in the highest quartile of the fraction of fatigue, calculated as the ESSPRI fatigue score divided by the total ESSPRI score. Thyroid stimulating hormone (TSH), free T4 (fT4), anti-thyroglobulin (TG), anti-thyroid peroxidase (TPO), and anti-TSH receptor antibody (TRAb) were measured.
RESULTS:
Of 196 patients, 31 (15.8%) were positive for anti-TG, 28 (14.3%) for anti-TPO, and 28 (14.3%) for TRAb. Subclinical hypothyroidism (S-Hypo) was identified in 23 (11.7%) patients. Anti-TG had no correlations with thyroidal function or pSS-related features. Meanwhile, anti-TPO was significantly associated with TSH levels or anti-centromere antibody. TRAb-positive patients exhibited significantly higher ESSDAI and clinical ESSDAI scores. Moreover, the most influential independent predictor for TRAb was lymphopenia (odds ratio [OR] = 5.541), which has been known as a prognostic factor. Additionally, significant bidirectional associations were found between the fatigue-dominant group (OR = 3.482) and anti-TPO-positive S-Hypo (OR = 7.586) in multivariate regression analyses.
CONCLUSIONS:
Latent thyroid autoimmunity, particularly TRAb and anti-TPO, may be associated with clinical and laboratory manifestations of pSS, such as disease activity or fatigue, even without overt thyroid dysfunction.
